» Authors » J Le Chenadec

J Le Chenadec

Explore the profile of J Le Chenadec including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 242
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dollfus C, Le Chenadec J, Faye A, Blanche S, Briand N, Rouzioux C, et al.
Clin Infect Dis . 2010 Jun; 51(2):214-24. PMID: 20536367
BACKGROUND. Increasing numbers of children perinatally infected with human immunodeficiency virus (HIV) are reaching adolescence, largely because of advances in treatment over the past 10 years, but little is known...
2.
Fourquet F, Le Chenadec J, Mayaux M, Meyer L
AIDS . 2001 Oct; 15(16):2193-6. PMID: 11684942
Pregnancy rates were compared before and after HIV diagnosis according to geographical origin (sub-Saharan Africa versus Europe) among 533 HIV-infected women followed in the French SEROCO/SEROGEST cohorts between 1988 and...
3.
Saada M, Le Chenadec J, Berrebi A, Bongain A, Delfraissy J, Mayaux M, et al.
AIDS . 2000 Nov; 14(15):2355-60. PMID: 11089624
Objective: To investigate whether pregnancy accelerates HIV-1 disease progression. Method: In two large French SEROCO and SEROGEST prospective cohorts of HIV infected patients, the progression to AIDS in 365 women...
4.
Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux M
Neurology . 2000 Mar; 54(5):1089-95. PMID: 10720279
Objective: To characterize the specificities of HIV-1-related encephalopathy in children. Methods: Comparison of patients from the French Perinatal Cohort of children born to HIV-1-infected mothers and followed from birth with...
5.
Hubert J, Burgard M, Dussaix E, Tamalet C, Deveau C, Le Chenadec J, et al.
AIDS . 2000 Mar; 14(2):123-31. PMID: 10708282
Objective: To describe the spontaneous course, before the introduction of highly active antiretroviral therapy (HAART), of HIV-1 RNA during the AIDS-free period of the disease. To assess the predictive value...
6.
Meyer L, Magierowska M, Hubert J, Mayaux M, Misrahi M, Le Chenadec J, et al.
J Infect Dis . 1999 Aug; 180(3):920-4. PMID: 10438395
This study attempted to determine whether the CCR5 Delta32 deletion affected progression to certain first AIDS-defining illnesses in human immunodeficiency virus type 1-infected patients enrolled in the French SEROCO/HEMOCO/SEROGEST cohorts....
7.
Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla J, Delfraissy J, et al.
JAMA . 1998 Jul; 280(1):55-60. PMID: 9660364
Context: It is unclear whether elective cesarean delivery may have a protective effect against the transmission of human immunodeficiency virus 1 (HIV-1). Objective: To investigate whether mode of delivery has...
8.
Mandelbrot L, Mayaux M, Bongain A, Berrebi A, Benifla J, Ciraru-Vigneron N, et al.
Am J Obstet Gynecol . 1996 Sep; 175(3 Pt 1):661-7. PMID: 8828431
Objective: We attempted to determine whether the risk of mother-to-child transmission of human immunodeficiency virus type 1 is related to events in pregnancy, labor, and delivery. Study Design: In a...
9.
Mayaux M, Blanche S, Rouzioux C, Le Chenadec J, Chambrin V, Firtion G, et al.
J Acquir Immune Defic Syndr Hum Retrovirol . 1995 Feb; 8(2):188-94. PMID: 7834401
A nationwide, longitudinal study of infants born to human immunodeficiency virus-seropositive mothers has been under way in France since 1986. After 7 years of follow-up observations, we will update our...